Half-dose photodynamic therapy for chronic central serous chorioretinopathy
Purpose: To report the outcomes of half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: A chart review of patients with chronic CSC who had received half-dose verteporfin PDT (3 mg/m2) was performed. The main outcome measures were resolution...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2016-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2016;volume=11;issue=1;spage=66;epage=69;aulast=Naseripour |